Cargando…
On the challenges of predicting treatment response in Hodgkin’s Lymphoma using transcriptomic data
BACKGROUND: Despite the advancements in multiagent chemotherapy in the past years, up to 10% of Hodgkin’s Lymphoma (HL) cases are refractory to treatment and, after remission, patients experience an elevated risk of death from all causes. These complications are dependent on the treatment and theref...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360230/ https://www.ncbi.nlm.nih.gov/pubmed/37474945 http://dx.doi.org/10.1186/s12920-023-01508-9 |